[1]苏海燕,陈怀霞,陈晓彤,等.四神丸合理中汤联合美沙拉嗪治疗溃疡性结肠炎作用机制研究[J].西部中医药,2023,36(01):92-95.[doi:10.12174/j.issn.2096-9600.2023.01.21]
　SU Haiyan,CHEN Huaixia,CHEN Xiaotong,et al.Study on the Mechanism of Sishen Pills, Lizhong Tang and Mesalazine in the Treatment of Ulcerative Colitis[J].Western Journal of Traditional Chinese Medicine,2023,36(01):92-95.[doi:10.12174/j.issn.2096-9600.2023.01.21]
点击复制

四神丸合理中汤联合美沙拉嗪治疗溃疡性结肠炎作用机制研究
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
36
期数:
2023年01期
页码:
92-95
栏目:
出版日期:
2023-01-15

文章信息/Info

Title:
Study on the Mechanism of Sishen Pills, Lizhong Tang and Mesalazine in the Treatment of Ulcerative Colitis
作者:
苏海燕1, 陈怀霞1, 陈晓彤2, 宋鹏1
1.甘肃中医药大学附属医院，甘肃 兰州 730000
2.临洮县中医院，甘肃 临洮 730500
Author(s):
SU Haiyan1, CHEN Huaixia1, CHEN Xiaotong2, SONG Peng1
1.Affiliated Hospital of Gansu University of Chinese Medicine, Lanzhou 730000, China
2.Lintao County Hospital of TCM, Lintao 730500, China
关键词:
溃疡性结肠炎; 辅助性T细胞22; 白细胞介素22; 四神丸; 理中汤; 美沙拉嗪
Keywords:
UC; Th22; IL-22; pills; mesalazine
分类号:
R259
DOI:
10.12174/j.issn.2096-9600.2023.01.21
文献标志码:
B
摘要:
目的探讨四神丸、理中汤联合美沙拉嗪治疗溃疡性结肠炎（ulcerative colitis，UC）的作用机制。 方法将UC患者162例使用随机数字表法分为对照组与联合组各81例。对照组予美沙拉嗪治疗，联合组予四神丸合理中汤联合美沙拉嗪治疗。记录两组患者治疗前及治疗3个月免疫功能指标｛辅助性T细胞22（T helper cell 22，Th22）、辅助性T细胞17（T helper cell 17，Th17）、血清免疫球蛋白［免疫球蛋白G(immunoglobulin G，IgG)、免疫球蛋白A(immunoglobulin A，IgA)］｝、血清炎症因子［白细胞介素22(interleukin-22，IL-22)、白细胞介素17（interleukin-17，IL-17）、肿瘤坏死因子α(tumor necrosis factor α，TNF-α)］、肠道菌群（肠球菌、乳酸菌、双歧杆菌、大肠杆菌）、血流动力学参数［红细胞压积（packed cell volume，PCV）、血浆黏度（plasma viscosity，PV）］水平，观察两组患者不良反应发生情况。 结果治疗3个月，两组患者免疫功能指标（Th22、Th17、IgG、IgA）、炎症因子（IL-22、IL-17、TNF-α）、血流动力学参数（PCV、PV）、粪便中大肠杆菌水平低于治疗前（P＜0.05），联合组低于对照组（P＜0.05）；乳酸菌、双歧杆菌高于治疗前（P＜0.05），联合组高于对照组（P＜0.05）。肠球菌联合组高于治疗前与治疗后对照组（P＜0.05），对照组与治疗前比较差异无统计学意义（P＞0.05）。两组患者治疗后不良反应发生率比较差异无统计学意义（P＞0.05）。 结论四神丸合理中汤联合美沙拉嗪有助于提高UC患者免疫功能，减轻患者肠道炎症反应。
Abstract:
ObjectiveTo explore the mechanism of Sishen pills, Lizhong Tang and mesalazine in treating UC. MethodsAll 162 UC patients were allocated to the control group and the combination group by using random number table method, with 81 cases in each group. The control group was treated by mesalazine, and the combination group by Sishen pills, Lizhong Tang and mesalazine. To record the indexes of immune function[(Th22, Th17), serum immunoglobulin (IgG, IgA)], serum inflammatory factors (IL-22, IL-17 and TNF-α), intestinal flora (enterococcus, lactobacillus, bifidobacterium and colibacillus), as well as the levels of hemodynamic parameters (PCV and PV) before treating and three months after the treatment between both groups, to observe the incidence of adverse reaction between both groups. ResultsThree months after the treatment, the levels of the indexes of immune function (Th22, Th17, IgG and IgA), serum inflammatory factors (IL-22, IL-17 and TNF-α), hemodynamic parameters (PCV and PV) and the levels of colibacillus in the excrement of both groups were lower than these before treating (P<0.05), the combination group was lower than the control group (P<0.05), the levels of lactobacillus and bifidobacterium were higher than these before treatment (P<0.05), the combination group was higher than the control group (P<0.05). The levels of enterococcus of the combination group were higher than these before treatment, and the control group after the treatment (P<0.05), the difference had no statistical meaning when the control group was compared with that before treatment (P>0.05). The difference had no statistical meaning in the incidence of adverse reaction between both groups after the treatment (P>0.05). ConclusionSishen pills, Lizhong Tang and mesalazine could help UC patients' immune function and relieve intestinal inflammatory reaction.

相似文献/References:

[1]李明彦,刘召.三黄汤口服并灌肠治疗溃疡性结肠炎临床观察[J].西部中医药,2014,27(11):127.
[2]崔童.肠安康胶囊联合美沙拉嗪治疗溃疡性结肠炎疗效观察[J].西部中医药,2015,28(01):78.
[3]孙军刚,刘琦,吴巧凤△.针刺对溃疡性结肠炎Th17/Treg免疫平衡的调节作用[J].西部中医药,2015,28(01):129.
[4]杨斌,王碧霞.美沙拉嗪栓联合穴位贴治疗溃疡性结肠炎中期效果探讨[J].西部中医药,2015,28(05):112.
[5]张军,叶玉伟.中医药治疗溃疡性结肠炎研究进展概况[J].西部中医药,2013,26(12):150.
　ZHANG Jun,YE Yuwei.A Survey of TCM in Treating Ulcerative Colitis[J].Western Journal of Traditional Chinese Medicine,2013,26(01):150.
[6]陈晨.中药保留灌肠治疗急性期溃疡性结肠炎的研究[J].西部中医药,2014,27(05):135.
　CHEN Chen.Research on Retention Enema with Herbs in Treating Ulcerative Colitis at Acute Exacerbation Stage[J].Western Journal of Traditional Chinese Medicine,2014,27(01):135.
[7]李有成,严文有,陈俊英,等.加味阳和四神汤/浸膏剂治疗慢性溃疡性结肠炎疗效观察[J].西部中医药,2014,27(05):104.
　LI Youcheng,YAN Wenyou,CHEN Junying,et al.Observation on Modified YangHe SiShen Decoction or Extract in Treating Chronic Ulcerative Colitis[J].Western Journal of Traditional Chinese Medicine,2014,27(01):104.
[8]王福亭.致康胶囊对溃疡性结肠炎患者血清TNF-α、IL-6及CRP的影响[J].西部中医药,2016,29(02):100.
　WANG Futing.Influence of ZhiKang Capsules on Serum TNF-α, IL-6 and CRP of the Patients with Ulcerative Colitis[J].Western Journal of Traditional Chinese Medicine,2016,29(01):100.
[9]张亮,王玮,邱连利△.温通针法治疗脾肾阳虚型溃疡性结肠炎35例[J].西部中医药,2017,30(12):100.
　ZHANG Liang,WANG Wei,QIU Lianli.Warming Needling Method in Treating 35 Cases of Ulcerative Colitis of Spleen-kidney Yang-deficiency Pattern[J].Western Journal of Traditional Chinese Medicine,2017,30(01):100.
[10]周春芳.强肝软坚汤加味治疗溃疡性结肠炎机制研究[J].西部中医药,2018,31(03):97.
　ZHOU Chunfang.Study on the Mechanism of Modified Liver-strengthening Mass-softening Decoction in Treating Ulcerative Colitis[J].Western Journal of Traditional Chinese Medicine,2018,31(01):97.

备注/Memo

备注/Memo:
苏海燕（1986—），女，硕士学位，主治医师。研究方向：中医内科脾胃病。甘肃省自然科学基金（1508RJZA018）。
更新日期/Last Update: 2023-01-15